Please login to the form below

Not currently logged in
Email:
Password:

NeuroVive

This page shows the latest NeuroVive news and features for those working in and with pharma, biotech and healthcare.

Sanofi licenses cardiovascular therapy in South Korea

Sanofi licenses cardiovascular therapy in South Korea

Sanofi licenses cardiovascular therapy in South Korea. Phase III drug comes from Swedish company NeuroVive. ... Sanofi has licensed an experimental drug from Swedish company NeuroVive that bolsters its cardiovascular therapy pipeline.

Latest news

  • inVentiv extends collaboration with NeuroVive inVentiv extends collaboration with NeuroVive

    inVentiv extends collaboration with NeuroVive. Will work on commercialisation of cardiac drug CicloMulsion. ... The partnership builds on a one-year regulatory consulting collaboration between NeuroVive and ParagonRx, inVentiv's risk mitigation service.

  • Collaboration on stroke therapy

    Collaboration on stroke therapy. NeuroVive Pharmaceutical and to-BBB are to work together to develop therapies for stroke and other acute neurodegenerative diseases. ... brain barrier (BBB) to significantly prevent drug penetration to the central nervous

  • Brain injury drug granted orphan status

    The Commission's decision is an affirmation of our development strategy," commented Mikael Brönnegård, chief executive officer of NeuroVive. ... patents for cyclosporine neuroprotection against chronic neurological diseases, remains NeuroVive's largest

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch table for September 2014 Deal Watch table for September 2014

    153. NeuroVive / OnCore. Licence and collaboration. NVP018 an oral sangamide-based 2nd generation cyclophilin inhibitor for hepatitis B.

  • Pharma deals during November 2012 Pharma deals during November 2012

    8. Sihuan Pharmaceutical / NeuroVive Pharmaceutical. Collaboration agreement. CicloMulsion / NeuroSTAT to treat heart reperfusion / traumatic brain injuries. ... Canadian research facility. South Korea market. Pursuant to the collaboration agreement,

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • NeuroVive appoints new chief executive officer NeuroVive appoints new chief executive officer

    The combination of his strategic vision and medical expertise is an excellent fit with NeuroVive's strategy refocused towards R&D.”. ... Kinnman said: “ I am excited about NeuroVive, the CEO role, and the opportunity to contribute to the success and

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics